ANI Pharmaceuticals
ANIP
ANIP
173 hedge funds and large institutions have $424M invested in ANI Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 66 increasing their positions, 53 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
12% less capital invested
Capital invested by funds: $480M → $424M (-$56.5M)
32% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 28
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
173
Holding in Top 10
1
Calls
$2.93M
Puts
$2.3M
Top Buyers
| 1 | +$6.53M | |
| 2 | +$3.96M | |
| 3 | +$3.25M | |
| 4 |
PFC
Phocas Financial Corp
Alameda,
California
|
+$3.11M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$3.03M |
Top Sellers
| 1 | -$3.22M | |
| 2 | -$3.14M | |
| 3 | -$2.34M | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$1.86M |
| 5 |
MSL
Mackay Shields LLC
New York
|
-$1.8M |